LUCIUS 卢修斯 司美替尼 Selumetinib纤维瘤

司美替尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Selumetinib

老挝国家食药监局批准上市
老挝国家药检所检测认证

Composition:

纤维瘤

Each capsule contains Selumctinib sultate
20.25mg equrvalent to Selumelinib ........ 2Sm

LUCiUS

Indication:

PHARMACEUTICALS

LuciSelume is a kinase inhibitor indicated for the
treatment of pediatric patients 2 vears of age and
older with neurofibromatosis type I (NFT] wh
have svmntomatic. inocershle nle
The recommended dosage is 25 mg/m taken

LuciSelume

orally fwice darly on an empty stomach. Do not
consume food2 hours before each dose or 1 ho

after eaek Ante

Selumetinib

* Keduce the recommended dosage to 20 mg m

Capsules

FDA批准

orally twice daily for patients with moderale

a dosage foruse in naiaeke
we on parment (Child-Pugh C)ha

25mg

en established.
Storage: in a dry place and store at 20°C to 25C.
Warning:
Keep medicine out of teach of Children. Do n
administered LuciSclume in Pregnancy and
ctation patient treatment.

PLEASE SEE PACKAGE INSERT

60 Capsules

Manufactured and Marketed by
LUCIUS

权威认证

Thongmang village. Xaythany district
Vientiane Capital, Laos
www.lucius.h
Warnlno: Tohos
warning : To he sold by retanl on prescrption
of registered pliysicians ool, and s d
by the physictan

Rx only

口碑质量

适应症。
适用于2岁及以上患有1型神经纤维瘤病(NF1)的儿童患者,这些
患者患有症状性、无法手术的丛状神经纤维瘤 PN)。
推荐剂量:
1、25mg/m2,每天2次(约每12小时一次),口服给药,直至疾病进
展或出现不可接受的毒性;
2、空腹服用(饭前1小时或饭后2小时);
3、整粒吞服,不要咀嚼,溶解或打开胶囊。